However, treatment with SGI-1776 inhibited growth (for MCL and AML), induced autophagy (for MM), and inhibited translation by negatively regulating phosphorylation of 4E-BP1. The gene discussed is EIF4EBP1; the disease is acute myeloid leukemia.